Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
L. Rigacci, B. Puccini, L. Iovino, M. Martelli, E. Finolezzi, S. Di Lollo, M. Doria & A. Bosi. (2011) Impact of Dose-Dense Immunochemotherapy on Prognosis of Germinal Center and Non Germinal Center Origin of Diffuse Large B Cell Lymphoma. Journal of Chemotherapy 23:4, pages 227-231.
Read now
Read now
Mattias Berglund, Göran Roos & Ulf Thunberg. (2009) Thymidylate syntase polymorphism relevant for survival in patients with diffuse large B-cell lymphoma?. Leukemia & Lymphoma 50:10, pages 1723-1725.
Read now
Read now
Articles from other publishers (16)
Danxia Zhu, Cheng Fang, Wenting He, Chen Wu, Xiaodong Li & Jun Wu. (2019)
MicroRNA-181a Inhibits Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Progression by Repressing
CARD11
. Journal of Oncology 2019, pages 1-9.
Crossref
Crossref
Huiying Qiu, Xiaoxia Hu, Lei Gao, Li Chen, Jie Chen, Joanna Yuan, Chongmei Huang, Xiaoqian Xu & Jianmin Yang. (2017) Interleukin 10 enhanced CD8+ T cell activity and reduced CD8+ T cell apoptosis in patients with diffuse large B cell lymphoma. Experimental Cell Research 360:2, pages 146-152.
Crossref
Crossref
Zhanshan Cha, Guangfang Qian, Yan Zang, Haihui Gu, Yanyan Huang, Lishuang Zhu, Jinqi Li, Yang Liu, Xiaohua Tu, Haihan Song & Baohua Qian. (2017) Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway. Experimental Cell Research 350:1, pages 154-160.
Crossref
Crossref
V Stefoni, B Casadei, C Bottelli, G Gaidano, C Ciochetto, M G Cabras, M Ansuinelli, L Argnani, A Broccoli, L Gandolfi, C Pellegrini & P L Zinzani. (2016) Short-course R-CHOP followed by 90Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results. Blood Cancer Journal 6:5, pages e425-e425.
Crossref
Crossref
Ellen Berget, Lars Helgeland, Knut Liseth, Turid Løkeland, Anders Molven & Olav Karsten Vintermyr. (2014) Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma. Journal of Clinical Pathology 67:12, pages 1072-1077.
Crossref
Crossref
Alejandra G. Erlejman, Mariana Lagadari, Judith Toneatto, Graciela Piwien-Pilipuk & Mario D. Galigniana. (2014) Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1839:2, pages 71-87.
Crossref
Crossref
Belinda A. Campbell. (2013) The Role of Radiation Therapy in the Treatment of Stage I-II Diffuse Large B-Cell Lymphoma. Current Hematologic Malignancy Reports 8:3, pages 236-242.
Crossref
Crossref
R. A. J. Nievelstein, H. M. E. Quarles van Ufford, T. C. Kwee, M. B. Bierings, I. Ludwig, F. J. A. Beek, J. M. H. de Klerk, W. P. Th. M. Mali, P. W. de Bruin & J. Geleijns. (2012) Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma. European Radiology 22:9, pages 1946-1954.
Crossref
Crossref
Belinda A. Campbell, Joseph M. Connors, Randy D. Gascoyne, W. James Morris, Tom Pickles & Laurie H. Sehn. (2012) Limited‐stage diffuse large B‐cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy. Cancer 118:17, pages 4156-4165.
Crossref
Crossref
Leandro C. Cerchietti, Katerina Hatzi, Eloisi Caldas-Lopes, Shao Ning Yang, Maria E. Figueroa, Ryan D. Morin, Martin Hirst, Lourdes Mendez, Rita Shaknovich, Philip A. Cole, Kapil Bhalla, Randy D. Gascoyne, Marco Marra, Gabriela Chiosis & Ari Melnick. (2010) BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy. Journal of Clinical Investigation 120:12, pages 4569-4582.
Crossref
Crossref
Pier Luigi Zinzani, Giuseppe Rossi, Silvia Franceschetti, Barbara Botto, Alice Di Rocco, Maria Giuseppina Cabras, Maria Concetta Petti, Vittorio Stefoni, Alessandro Broccoli, Stefano Fanti, Cinzia Pellegrini, Gian Carlo Montini, Letizia Gandolfi, Enrico Derenzini, Lisa Argnani, Mariapaola Fina, Alessandra Tucci, Chiara Bottelli, Stefano Pileri & Michele Baccarani. (2010) Phase II Trial of Short-Course R-Chop Followed by 90Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients. Clinical Cancer Research 16:15, pages 3998-4004.
Crossref
Crossref
Franck Morschhauser, Martin Dreyling, Ama Rohatiner, Fredrick Hagemeister & Angelika Bischof Delaloye. (2009) Rationale for Consolidation to Improve Progression-Free Survival in Patients with Non-Hodgkin’s Lymphoma: A Review of the Evidence. The Oncologist 14:S2, pages 17-29.
Crossref
Crossref
M. Berglund, G. Enblad, I. Turesson, V. Edman & U. Thunberg. (2009) Folate-Metabolizing Genes in Lymphoma Patients from Sweden. Scandinavian Journal of Immunology 70:4, pages 408-410.
Crossref
Crossref
Paul B. Romesser, David H. Perlman, Douglas V. Faller, Catherine E. Costello, Mark E. McComb & Gerald V. Denis. (2009) Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma. The American Journal of Pathology 175:1, pages 25-35.
Crossref
Crossref
Kiriko Wada, Kunihiko Maeda, Katsushi Tajima, Takeo Kato, Tetsuji Kobata & Mitsunori Yamakawa. (2009) Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas. Histopathology 54:2, pages 221-232.
Crossref
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref
Crossref